Melbourne Urologist
Mr Pras Sivam FRACS FUSANZ

Mr Pras Sivam FRACS FUSANZ

Urologist, Uro-Oncologist and Robotic Surgeon

Pras Sivam is a highly qualified and experienced urologist with expertise in the treatment of urological cancers. He holds a Fellowship of the Royal Australasian College of Surgeons and is a Member of the Society of Urologic Oncology.

Pras grew up in Melbourne and attended Haileybury College, where he graduated as Dux of the School in 1998. He then went on to study at the University of Melbourne Medical School, where he was accepted with the top tertiary entrance rank of 99.95. After completing his postgraduate surgical training in Victoria, he was offered a Fellowship in Urologic Oncology at Memorial Sloan-Kettering Cancer Center in New York. This gave him the opportunity to receive specialized training from world-renowned experts in his field.

Pras offers a range of general urologic services, with a focus on the latest surgical techniques for treating urological cancers. Click here to learn more about his background, qualifications, and services.

Melbourne Urologist Robotic Prostatectomy Prostate Cancer

Please click below for detailed descriptions of common operations, including robotic prostatectomy, prostate biopsy, stone surgery, TURP and surgery for kidney, bladder and testis cancer. 

The "Hood Technique"

Dr Pras utilises the “Hood Technique” for robotic radical prostatectomy (1). This approach combines elements of both the traditional “anterior” and newer “Retzius-sparing” techniques to enable early return of continence without compromising surgical margin rates.

Early continence recovery

In a recent audit of the last 50 cases using the Hood Technique, we found that 37% of our patients achieved continence (0 pads or 1 security pad) within 2 weeks of surgery, and 57% within 3 months. Few studies have looked at continence this early after surgery, however one large systematic review reported 3-month continence rates ranging from 25% to 90% (2).

Excellent cancer control

In a recent audit of the last 50 cases using the Hood Technique, we achieved superior cancer control rates with a negative margin rate of 100% for organ-confined cancer (stage pT2) and 82% for locally-advanced cancer (stage pT3). For comparison, in one large systematic review the average negative margin rate was 91% for pT2 and 63% for pT3 cancers (3).

(1) Wagaskar et al. European Urology, Volume 80, Issue 2August 2021, Pages 213-221.

(2) Ficarra et al. European Urology, Volume 62 Issue 3, September 2012, Pages 405-417.

(3) Novara et al. European Urology, Volume 62 Issue 3, September 2012, Pages 382-404.

robotic prostatectomy

Prostate Cancer

Should you have a PSA test? How do we diagnose and treat prostate cancer? How do we manage the side-effects of treatment?

Robotic prostatectomy

Bladder Cancer

What causes bladder cancer? When must we remove the entire bladder with surgery?

Robotic prostatectomy

Kidney Cancer

What is the role of biopsy in kidney cancer? Do all kidney tumours need surgery? When can we watch a kidney tumour?

Robotic prostatectomy

Testis Cancer

What are the symptoms of testis cancer? How is it treated and can it be cured?

Benign Enlarged Prostate

What are the symptoms of having an enlarged prostate? What treatment options are available?

Melbourne Urologist

Kidney Stones

What causes kidney stones and what can I do to prevent them? How do we treat kidney stones?

In the news – Alban Gee Award

Dr. Pras was recently honoured with the prestigious 2022 Alban Gee Award at the Annual Meeting of the Urological Society of Australia and New Zealand, which took place at the Gold Coast Convention Centre. This award has been presented annually since 1987 to recognize the best poster by a USANZ member at the Annual Scientific Meeting.

Dr. Pras’s winning poster, titled “Factors impacting clinician reluctance to defer prostate biopsy in men with a negative multiparametric MRI,” addressed the issue of doctors who remain reluctant to defer prostate biopsy in men with negative MRI findings. His research has shed light on an important issue in the field of urology and has garnered recognition from his peers.

 

Melbourne Urologist
Melbourne Urologist
Melbourne Urologist
Melbourne Urologist